Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2015 Apr 1;68(4):377–385. doi: 10.1097/QAI.0000000000000500

Figure 3.

Figure 3

Percentages of activated (CD38+HLA-DR+) CD8+ T cells (A) and level of sCD14 (pg/mL) in the plasma (B) among HIV-uninfected participants, Elite Controllers (EC), Ebbing Elite Controllers (EEC), Viremic Controllers (VC) and Non-Controllers (NC). The horizontal bars denote median values. P values for comparison between two groups were calculated using a 2-tailed Mann-Whitney test.